img

Global Bacille Calmette-Guérin Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bacille Calmette-Guérin Vaccine Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Bacille Calmette-Guérin Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bacille Calmette-Guérin Vaccine market research.
Key manufacturers engaged in the Bacille Calmette-Guérin Vaccine industry include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India and GSBPL, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Bacille Calmette-Guérin Vaccine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Bacille Calmette-Guérin Vaccine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bacille Calmette-Guérin Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
GSBPL
Segment by Type
Immune Bacille Calmette-Guérin
Therapy Bacille Calmette-Guérin

Segment by Application


Infants Under 3 Months
Children Test Negative With 5IUPPD

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Bacille Calmette-Guérin Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Bacille Calmette-Guérin Vaccine Market Overview
1.1 Product Overview and Scope of Bacille Calmette-Guérin Vaccine
1.2 Bacille Calmette-Guérin Vaccine Segment by Type
1.2.1 Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Immune Bacille Calmette-Guérin
1.2.3 Therapy Bacille Calmette-Guérin
1.3 Bacille Calmette-Guérin Vaccine Segment by Application
1.3.1 Global Bacille Calmette-Guérin Vaccine Market Value by Application: (2024-2034)
1.3.2 Infants Under 3 Months
1.3.3 Children Test Negative With 5IUPPD
1.4 Global Bacille Calmette-Guérin Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bacille Calmette-Guérin Vaccine Revenue 2024-2034
1.4.2 Global Bacille Calmette-Guérin Vaccine Sales 2024-2034
1.4.3 Global Bacille Calmette-Guérin Vaccine Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Bacille Calmette-Guérin Vaccine Market Competition by Manufacturers
2.1 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Manufacturers (2024-2024)
2.2 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Bacille Calmette-Guérin Vaccine Average Price by Manufacturers (2024-2024)
2.4 Global Bacille Calmette-Guérin Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Product Type & Application
2.7 Bacille Calmette-Guérin Vaccine Market Competitive Situation and Trends
2.7.1 Bacille Calmette-Guérin Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bacille Calmette-Guérin Vaccine Players Market Share by Revenue
2.7.3 Global Bacille Calmette-Guérin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bacille Calmette-Guérin Vaccine Retrospective Market Scenario by Region
3.1 Global Bacille Calmette-Guérin Vaccine Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Bacille Calmette-Guérin Vaccine Global Bacille Calmette-Guérin Vaccine Sales by Region: 2024-2034
3.2.1 Global Bacille Calmette-Guérin Vaccine Sales by Region: 2024-2024
3.2.2 Global Bacille Calmette-Guérin Vaccine Sales by Region: 2024-2034
3.3 Global Bacille Calmette-Guérin Vaccine Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2024-2034
3.3.1 Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2024-2024
3.3.2 Global Bacille Calmette-Guérin Vaccine Revenue by Region: 2024-2034
3.4 North America Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.4.1 North America Bacille Calmette-Guérin Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034)
3.4.3 North America Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.5.1 Europe Bacille Calmette-Guérin Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034)
3.5.3 Europe Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Bacille Calmette-Guérin Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034)
3.6.3 Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bacille Calmette-Guérin Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034)
3.7.3 Latin America Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bacille Calmette-Guérin Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacille Calmette-Guérin Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034)
3.8.3 Middle East and Africa Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacille Calmette-Guérin Vaccine Sales by Type (2024-2034)
4.1.1 Global Bacille Calmette-Guérin Vaccine Sales by Type (2024-2024)
4.1.2 Global Bacille Calmette-Guérin Vaccine Sales by Type (2024-2034)
4.1.3 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2024-2034)
4.2.1 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2024-2024)
4.2.2 Global Bacille Calmette-Guérin Vaccine Revenue by Type (2024-2034)
4.2.3 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Bacille Calmette-Guérin Vaccine Price by Type (2024-2034)
5 Segment by Application
5.1 Global Bacille Calmette-Guérin Vaccine Sales by Application (2024-2034)
5.1.1 Global Bacille Calmette-Guérin Vaccine Sales by Application (2024-2024)
5.1.2 Global Bacille Calmette-Guérin Vaccine Sales by Application (2024-2034)
5.1.3 Global Bacille Calmette-Guérin Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2024-2034)
5.2.1 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2024-2024)
5.2.2 Global Bacille Calmette-Guérin Vaccine Revenue by Application (2024-2034)
5.2.3 Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Bacille Calmette-Guérin Vaccine Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck Bacille Calmette-Guérin Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Japan BCG Lab Bacille Calmette-Guérin Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 China National Biotec Bacille Calmette-Guérin Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Serum Institute of India Bacille Calmette-Guérin Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL Bacille Calmette-Guérin Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.6.4 GSBPL Bacille Calmette-Guérin Vaccine Product Portfolio
6.6.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacille Calmette-Guérin Vaccine Industry Chain Analysis
7.2 Bacille Calmette-Guérin Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacille Calmette-Guérin Vaccine Production Mode & Process
7.4 Bacille Calmette-Guérin Vaccine Sales and Marketing
7.4.1 Bacille Calmette-Guérin Vaccine Sales Channels
7.4.2 Bacille Calmette-Guérin Vaccine Distributors
7.5 Bacille Calmette-Guérin Vaccine Customers
8 Bacille Calmette-Guérin Vaccine Market Dynamics
8.1 Bacille Calmette-Guérin Vaccine Industry Trends
8.2 Bacille Calmette-Guérin Vaccine Market Drivers
8.3 Bacille Calmette-Guérin Vaccine Market Challenges
8.4 Bacille Calmette-Guérin Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Bacille Calmette-Guérin Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Bacille Calmette-Guérin Vaccine Sales (Units) of Key Manufacturers (2024-2024)
Table 5. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Bacille Calmette-Guérin Vaccine Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Bacille Calmette-Guérin Vaccine Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Bacille Calmette-Guérin Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Bacille Calmette-Guérin Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bacille Calmette-Guérin Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacille Calmette-Guérin Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bacille Calmette-Guérin Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Bacille Calmette-Guérin Vaccine Sales by Region (2024-2024) & (Units)
Table 18. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Region (2024-2024)
Table 19. Global Bacille Calmette-Guérin Vaccine Sales by Region (2024-2034) & (Units)
Table 20. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Bacille Calmette-Guérin Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Region (2024-2024)
Table 23. Global Bacille Calmette-Guérin Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Bacille Calmette-Guérin Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Bacille Calmette-Guérin Vaccine Sales by Country (2024-2024) & (Units)
Table 27. North America Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034) & (Units)
Table 28. North America Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Bacille Calmette-Guérin Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Bacille Calmette-Guérin Vaccine Sales by Country (2024-2024) & (Units)
Table 32. Europe Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034) & (Units)
Table 33. Europe Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Bacille Calmette-Guérin Vaccine Sales by Region (2024-2024) & (Units)
Table 37. Asia Pacific Bacille Calmette-Guérin Vaccine Sales by Region (2024-2034) & (Units)
Table 38. Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Bacille Calmette-Guérin Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Bacille Calmette-Guérin Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Bacille Calmette-Guérin Vaccine Sales by Country (2024-2024) & (Units)
Table 42. Latin America Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034) & (Units)
Table 43. Latin America Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Bacille Calmette-Guérin Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Bacille Calmette-Guérin Vaccine Sales by Country (2024-2024) & (Units)
Table 47. Middle East & Africa Bacille Calmette-Guérin Vaccine Sales by Country (2024-2034) & (Units)
Table 48. Middle East & Africa Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Bacille Calmette-Guérin Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Bacille Calmette-Guérin Vaccine Sales (Units) by Type (2024-2024)
Table 51. Global Bacille Calmette-Guérin Vaccine Sales (Units) by Type (2024-2034)
Table 52. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Type (2024-2024)
Table 53. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Type (2024-2024)
Table 57. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Type (2024-2024)
Table 59. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Bacille Calmette-Guérin Vaccine Sales (Units) by Application (2024-2024)
Table 61. Global Bacille Calmette-Guérin Vaccine Sales (Units) by Application (2024-2034)
Table 62. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Application (2024-2024)
Table 63. Global Bacille Calmette-Guérin Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Bacille Calmette-Guérin Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Application (2024-2024)
Table 67. Global Bacille Calmette-Guérin Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Application (2024-2024)
Table 69. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Merck Bacille Calmette-Guérin Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Sanofi Pasteur Bacille Calmette-Guérin Vaccine Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Japan BCG Lab Corporation Information
Table 81. Japan BCG Lab Description and Business Overview
Table 82. Japan BCG Lab Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Japan BCG Lab Bacille Calmette-Guérin Vaccine Product
Table 84. Japan BCG Lab Recent Developments/Updates
Table 85. China National Biotec Corporation Information
Table 86. China National Biotec Description and Business Overview
Table 87. China National Biotec Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. China National Biotec Bacille Calmette-Guérin Vaccine Product
Table 89. China National Biotec Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Serum Institute of India Bacille Calmette-Guérin Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. GSBPL Corporation Information
Table 96. GSBPL Description and Business Overview
Table 97. GSBPL Bacille Calmette-Guérin Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. GSBPL Bacille Calmette-Guérin Vaccine Product
Table 99. GSBPL Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Bacille Calmette-Guérin Vaccine Distributors List
Table 103. Bacille Calmette-Guérin Vaccine Customers List
Table 104. Bacille Calmette-Guérin Vaccine Market Trends
Table 105. Bacille Calmette-Guérin Vaccine Market Drivers
Table 106. Bacille Calmette-Guérin Vaccine Market Challenges
Table 107. Bacille Calmette-Guérin Vaccine Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bacille Calmette-Guérin Vaccine
Figure 2. Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Bacille Calmette-Guérin Vaccine Market Share by Type in 2022 & 2034
Figure 4. Immune Bacille Calmette-Guérin Product Picture
Figure 5. Therapy Bacille Calmette-Guérin Product Picture
Figure 6. Global Bacille Calmette-Guérin Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Bacille Calmette-Guérin Vaccine Market Share by Application in 2022 & 2034
Figure 8. Infants Under 3 Months
Figure 9. Children Test Negative With 5IUPPD
Figure 10. Global Bacille Calmette-Guérin Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 11. Global Bacille Calmette-Guérin Vaccine Market Size (2024-2034) & (US$ Million)
Figure 12. Global Bacille Calmette-Guérin Vaccine Sales (2024-2034) & (Units)
Figure 13. Global Bacille Calmette-Guérin Vaccine Average Price (US$/Unit) & (2024-2034)
Figure 14. Bacille Calmette-Guérin Vaccine Report Years Considered
Figure 15. Bacille Calmette-Guérin Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Bacille Calmette-Guérin Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Bacille Calmette-Guérin Vaccine Players: Market Share by Revenue in 2022
Figure 18. Bacille Calmette-Guérin Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 19. Global Bacille Calmette-Guérin Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 20. North America Bacille Calmette-Guérin Vaccine Sales Market Share by Country (2024-2034)
Figure 21. North America Bacille Calmette-Guérin Vaccine Revenue Market Share by Country (2024-2034)
Figure 22. United States Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 23. Canada Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Europe Bacille Calmette-Guérin Vaccine Sales Market Share by Country (2024-2034)
Figure 25. Europe Bacille Calmette-Guérin Vaccine Revenue Market Share by Country (2024-2034)
Figure 26. Germany Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. France Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. U.K. Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Italy Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Russia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Asia Pacific Bacille Calmette-Guérin Vaccine Sales Market Share by Region (2024-2034)
Figure 32. Asia Pacific Bacille Calmette-Guérin Vaccine Revenue Market Share by Region (2024-2034)
Figure 33. China Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Japan Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. South Korea Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. India Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Australia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. China Taiwan Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Southeast Asia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Latin America Bacille Calmette-Guérin Vaccine Sales Market Share by Country (2024-2034)
Figure 41. Latin America Bacille Calmette-Guérin Vaccine Revenue Market Share by Country (2024-2034)
Figure 42. Mexico Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Brazil Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Argentina Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Bacille Calmette-Guérin Vaccine Sales Market Share by Country (2024-2034)
Figure 46. Middle East & Africa Bacille Calmette-Guérin Vaccine Revenue Market Share by Country (2024-2034)
Figure 47. Turkey Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Saudi Arabia Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. UAE Bacille Calmette-Guérin Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Global Sales Market Share of Bacille Calmette-Guérin Vaccine by Type (2024-2034)
Figure 51. Global Revenue Market Share of Bacille Calmette-Guérin Vaccine by Type (2024-2034)
Figure 52. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Type (2024-2034)
Figure 53. Global Sales Market Share of Bacille Calmette-Guérin Vaccine by Application (2024-2034)
Figure 54. Global Revenue Market Share of Bacille Calmette-Guérin Vaccine by Application (2024-2034)
Figure 55. Global Bacille Calmette-Guérin Vaccine Price (US$/Unit) by Application (2024-2034)
Figure 56. Bacille Calmette-Guérin Vaccine Value Chain
Figure 57. Bacille Calmette-Guérin Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed